187 related articles for article (PubMed ID: 22438068)
1. Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma.
Knösel T; Chen Y; Hotovy S; Settmacher U; Altendorf-Hofmann A; Petersen I
Int J Colorectal Dis; 2012 Nov; 27(11):1391-9. PubMed ID: 22438068
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma.
Hamidov Z; Altendorf-Hofmann A; Chen Y; Settmacher U; Petersen I; Knösel T
J Clin Pathol; 2011 Nov; 64(11):990-4. PubMed ID: 21725043
[TBL] [Abstract][Full Text] [Related]
3. Desmocollin switching in colorectal cancer.
Khan K; Hardy R; Haq A; Ogunbiyi O; Morton D; Chidgey M
Br J Cancer; 2006 Nov; 95(10):1367-70. PubMed ID: 17088906
[TBL] [Abstract][Full Text] [Related]
4. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2.
Funakoshi S; Ezaki T; Kong J; Guo RJ; Lynch JP
Mol Cancer Res; 2008 Sep; 6(9):1478-90. PubMed ID: 18819935
[TBL] [Abstract][Full Text] [Related]
5. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic impact of desmocollins in human lung cancer.
Cui T; Chen Y; Yang L; Mireskandari M; Knösel T; Zhang Q; Kohler LH; Kunze A; Presselt N; Petersen I
J Clin Pathol; 2012 Dec; 65(12):1100-6. PubMed ID: 23002285
[TBL] [Abstract][Full Text] [Related]
7. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.
Cui T; Chen Y; Yang L; Knösel T; Zöller K; Huber O; Petersen I
Br J Cancer; 2011 Mar; 104(6):1013-9. PubMed ID: 21364582
[TBL] [Abstract][Full Text] [Related]
8. Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer.
Cui T; Yang L; Ma Y; Petersen I; Chen Y
Exp Cell Res; 2019 May; 378(2):124-130. PubMed ID: 30857973
[TBL] [Abstract][Full Text] [Related]
9. Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype.
Anami K; Oue N; Noguchi T; Sakamoto N; Sentani K; Hayashi T; Hinoi T; Okajima M; Graff JM; Yasui W
J Pathol; 2010 Jul; 221(3):275-84. PubMed ID: 20527021
[TBL] [Abstract][Full Text] [Related]
10. The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer.
Grimminger P; Ling FC; Neiss S; Vallböhmer D; Lurje G; Schneider PM; Hölscher AH; Metzger R; Brabender J
Anticancer Res; 2009 Apr; 29(4):1281-6. PubMed ID: 19414376
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
Zheng J; Sun X; Wang W; Lu S
Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
[TBL] [Abstract][Full Text] [Related]
12. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
[TBL] [Abstract][Full Text] [Related]
13. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation downregulates CDX2 expression in colorectal carcinomas.
Kawai H; Tomii K; Toyooka S; Yano M; Murakami M; Tsukuda K; Shimizu N
Oncol Rep; 2005 Mar; 13(3):547-51. PubMed ID: 15706431
[TBL] [Abstract][Full Text] [Related]
15. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
[TBL] [Abstract][Full Text] [Related]
16. A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype.
Bartolomé RA; Pintado-Berninches L; Martín-Regalado Á; Robles J; Calvo-López T; Ortega-Zapero M; Llorente-Sáez C; Boukich I; Fernandez-Aceñero MJ; Casal JI
J Exp Clin Cancer Res; 2024 Jan; 43(1):31. PubMed ID: 38263178
[TBL] [Abstract][Full Text] [Related]
17. The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.
Schüle S; Neuhäuser C; Rauchfuß F; Knösel T; Settmacher U; Altendorf-Hofmann A
Int J Colorectal Dis; 2014 Jan; 29(1):9-14. PubMed ID: 23975055
[TBL] [Abstract][Full Text] [Related]
18. Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance.
Chen YN; Chen H; Xu Y; Zhang X; Luo Y
World J Gastroenterol; 2008 Jan; 14(2):292-7. PubMed ID: 18186570
[TBL] [Abstract][Full Text] [Related]
19. CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma.
Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
